The phrase "a decrease in disease" is correct and usable in written English.
It can be used in contexts discussing health, public health initiatives, or epidemiology to indicate a reduction in the prevalence or incidence of diseases.
Example: "The new vaccination program has led to a significant decrease in disease among children in the community."
Alternatives: "a reduction in illness" or "a decline in disease prevalence."
"We're hopeful these figures really reflect a decrease in disease," said Dr. Caroline Ryan, associate director for international activities in the division of sexually transmitted disease prevention in the Centers for Disease Control and Prevention in Atlanta.
Specific changes in expression during pregnancy were associated with a decrease in disease activity assessed by occurrence of relapses during pregnancy.
Furthermore, analysis focused on recrudescent females revealed that maternal mortality associated to recrudescence decreases with parity (Table 1) suggesting a decrease in disease severity.
Previously, the addition of recombinant IL-6 following encephalomyocarditis virus (EMCV) infection resulted in a decrease in disease severity of autoimmune myocarditis [3].
Nevertheless, although further studies on PBMCs subsets are logically needed, it is notable that presented changes are associated with a decrease in disease activity assessed by the occurrence of relapses during pregnancy.
For example, 6 of the 7 mice treated with 1 mg/kg/day of gemcitabine received a score of 1, whereas all of the lymph nodes from mice treated with either 2 or 3 mg/kg/day received scores that were consistent with a decrease in disease progression when compared to the untreated but infected mice or mice treated with 1 mg/kg/day of gemcitabine.
The presence of galanin promoter hypermethylation was statistically correlated with a decrease in disease-free survival (log-rank test, P = 6.02E-05).
Additionally, the care and treatment of patients with type 1 diabetes has seen a rapid evolution; with genetically engineered insulins, glucose monitoring devices, and algorithms all contributing to a decrease in disease-related complications.
Overexpression of Erk5 was associated with a decrease in disease-free survival time, which was independent of other clinicopathological parameters of prognosis.
It has also been shown that in breast cancer, p53 mutations are associated with a decrease in disease-free and overall survival of patients (Sirvent et al, 2001).
Breast cancer patients with HER2/neu overexpression have poor outcomes with a decrease in disease-free survival (DFS) and overall survival.
